Key Takeaways A COPD treatment for former smokers developed by Regeneron Pharmaceuticals and Sanofi failed to meet its ...

Analysts at Truist Securities admitted that the result for itepekimab, which the companies were hoping to follow their ...

Analyst Brian Abrahams reiterated an Outperform rating and a price target of $943 for Regeneron Pharmaceuticals, Inc. (NASDAQ ...

Skolnik said, “For example, pulmonary function tests like spirometry are very helpful in gaining insight as to whether ...

The US Food and Drug Administration (FDA) has approved mepolizumab as a maintenance treatment for chronic obstructive ...

UK-based Verona Pharma has scored a key win in a phase 3 trial of its chronic obstructive pulmonary disease (COPD) drug ensifentrine, setting up regulatory filings in the first half of next year.

The COPD approval marks the fifth Nucala has received from the FDA, following green lights in severe asthma, chronic ...

A new study highlights the Cardio-Ankle Vascular Index (CAVI) as a powerful tool for predicting COPD progression and outcomes ...

Women with COPD, asthma, and OSA may go undiagnosed or without proper care because their symptomatology differs from the classic male presentation.

When you are diagnosed with COPD, it is important to remember that you are not alone. A healthcare team, which may include a ...

Researchers also analyzed drug safety and scores on the COPD Assessment Test (CAT), St. George’s Respiratory Questionnaire (SGRQ) and Evaluating Respiratory Symptoms in COPD (E-RS-COPD ...

Both AATD and COPD are conditions that can lead to breathing ... Ph.D., lead researcher and senior author on the paper. "Our test provides an accurate, comprehensive and rapid genotyping solution ...